Quantcast

Latest Robert Lanza Stories

Cloning Breakthrough: Viable Stem Cells Created From Adult Donor
2014-04-18 09:22:35

Brett Smith for redOrbit.com - Your Universe Online In a significant breakthrough a team of scientists from California and Seoul, South Korea have been able to create viable stem cells from an adult donor that perfectly match the donor’s DNA, according to a new report in the journal Cell Stem Cell. The development, referred to as "therapeutic cloning,” involves the production of embryonic cells for scientific purposes and many object to this type of research based on moral or...

Is the Universe the creation of consciousness
2013-11-15 13:43:03

Brett Smith for redOrbit.com - Your Universe Online While opinions about the existence of heaven or hell are firmly entrenched in the public consciousness, a Wake Forest stem cell scientist has put forward a theory that says death is just a construct of the human mind. In his theory, called biocentrism, Dr. Robert Lanza claims the universe is created by life, not the other way around. The theory posits that a person's consciousness determines the appearance and behavior of objects in...

First European Embryonic Stem Cell Trial Approved
2011-09-23 06:30:06

  The first ever European trials of human embryonic stem cell therapy will take place before the end of the year, various media outlets reported on Thursday. According to Guardian Science Correspondent Ian Sample, the trial will take place at Moorfields Eye Hospital in London, and will involve treatment of a form of juvenile blindness known as Stargardt's macular dystrophy. "Massachusetts-based ACT will start the trial of its treatment, which uses retinal pigment epithelium...

2011-07-21 07:30:00

MARLBOROUGH, Mass., July 21, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has entered into an agreement with CHA Bio & Diostech Co, Ltd. ("CHA Biotech"), a leading South Korea-based biotechnology company, designed to enhance the efforts of the two companies' international joint venture, Stem Cell & Regenerative Medicine International (SCRMI). Under the terms of the agreement, SCRMI...

2011-07-14 07:30:00

MARLBOROUGH, Mass., July 14, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced the dosing of the first patients in each of its two Phase 1/2 clinical trials for Stargardt's macular dystrophy and dry age-related macular degeneration (dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The patients were treated Tuesday (July 12) by Steven Schwartz, M.D.,...

2011-06-21 07:30:00

MARLBOROUGH, Mass., June 21, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has entered into a definitive collaborative agreement with Roslin Cells LTD ("Roslin Cells") of Scotland. The two companies will work together to establish a bank of Good Manufacturing Practice (GMP)-grade human embryonic stem cell (hESC) lines using ACT's patented, proprietary "single-cell blastomere" technique for...

216f1e2c8e43683d7c2bda043fb9a614
2011-06-17 12:40:00

The first two patients with common but incurable diseases of the eye that can lead to blindness have been enrolled early in a two phase groundbreaking clinical trial of therapy that researchers are hoping will heal the damage caused by the conditions. Advanced Cell Technology Inc. (ACT) announced Thursday the enrollment of the patients in the trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD). The patients were enrolled at the Jules Stein Eye...

2011-06-16 07:59:00

MARLBOROUGH, Mass., June 16, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The patients were enrolled at the Jules Stein Eye Institute at the...

2011-05-05 07:30:00

MARLBOROUGH, Mass., May 5, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that interim chairman and CEO Gary Rabin will be presenting at the World Stem Cells & Regenerative Medicine Congress, May 9-11, in London. Mr. Rabin's presentation, titled "Using ESC-Derived RPE Cells for Dry AMD and Stargardt's Disease," will be given on Monday, May 9. In it, he will provide an update on ACT's...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related